Next Article in Journal / Special Issue
Marine Drugs from Sponge-Microbe Association—A Review
Previous Article in Journal
The Outer Vestibule of the Na+ Channel–Toxin Receptor and Modulator of Permeation as Well as Gating
Previous Article in Special Issue
Microtubule-Stabilizing Drugs from Marine Sponges: Focus on Peloruside A and Zampanolide
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Marine Drugs
Volume 8
Issue 4
10.3390/md8041394
marinedrugs-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Synthesis of the Marine Pyrroloiminoquinone Alkaloids, Discorhabdins

by
Yasufumi Wada
1,,
Hiromichi Fujioka
1,* and
Yasuyuki Kita
1,*
1
Graduate School of Pharmaceutical Sciences, Osaka University, 1-6 Yamada-oka, Suita, Osaka, 565-0871, Japan
2
College of Pharmaceutical Sciences, Ritsumeikan University, 1-1-1 Nojihigashi, Kusatsu, Shiga, 525-8577, Japan
*
Authors to whom correspondence should be addressed.
JSPS Research Fellow.
Mar. Drugs 2010, 8(4), 1394-1416; https://doi.org/10.3390/md8041394
Submission received: 7 April 2010 / Revised: 16 April 2010 / Accepted: 19 April 2010 / Published: 21 April 2010
(This article belongs to the Special Issue Bioactive Compound from Marine Sponges)
Browse Figures
Versions Notes

Abstract

:
Many natural products with biologically interesting structures have been isolated from marine animals and plants such as sponges, corals, worms, etc. Some of them are discorhabdin alkaloids. The discorhabdin alkaloids (discorhabdin A-X), isolated from marine sponges, have a unique structure with azacarbocyclic spirocyclohexanone and pyrroloiminoquinone units. Due to their prominent potent antitumor activity, discorhabdins have attracted considerable attention. Many studies have been reported toward the synthesis of discorhabdins. We have accomplished the first total synthesis of discorhabdin A (1), having the strongest activity in vitro among discorhabdins in 2003. In 2009, we have also accomplished the first total synthesis of prianosin B (2), having the 16,17-dehydropyrroloiminoquinone moiety, by a novel dehydrogenation reaction with a catalytic amount of NaN3. These synthetic studies, as well as syntheses of the discorhabdins by various chemists to-date, are reviewed here.

1. Introduction

Marine organisms contain various elements that are important for their survival and for their relationships with other living bodies. The nature, action and role of many of these elements have not yet been elucidated. Many marine organic compounds have been shown to be also useful for humans; as drugs, agricultural medicines, cosmetics and health foods [1–5]. In particular, a number of marine drugs have been developed in recent years. Marine natural products offer challenging targets to synthetic chemists due to their complicated structures that exhibit remarkable biological activities [6–11]. However, the chemical synthesis of marine drugs is of upmost importance as a synthetic supply is needed when it is difficult to maintain the amount of the natural source.
In the past several years, many new pyrroloiminoquinone alkaloids have been isolated from marine sources. The pyrroloiminoquinone alkaloid family consists of discorhabdins [12–16], prianosins [17], makaluvamines [18–21], batzellins [22–23], wakayins [24] and damirones [25–26], and have potent antitumor activities derived from their unique fused ring structures [27]. Among them, the discorhabdin alkaloids were isolated from marine sponges such as New Zealand sponges of the genus Latrunculia, the Okinawan sponge Prianos melanos, the Fijian sponge Zyzzya cf. Marsailis, etc. [12–16]. All of them have unique structures, with azacarbocyclic spirocyclohexanone and pyrroloiminoquinone structures. Figure 1 shows some representative discorhabdin alkaloids. Among the various isolated discorhabdins (A–X), discorhabdins A (1) [28,29], B (4) [28,29], D (3) [30], H [15], I [14], J [12], L [14], M [12], N [12], Q (5) [31], R [32], X (6) [33], and prianosins B (2), D [34] have a sulfur-containing fused ring structure. Discorhabdins S (11), T (12) and U (13) [13] have a methyl sulfide moiety. Discorhabdin W (14) [35] is a dimeric structure with a disulfide bond, while the others have no sulfur atom. Furthermore, discorhabdins F (9) [36], Q, S, T and prianosin B (2) contain a 16,17-dehydropyrroloiminoquinone moiety. Because of their prominent potent antitumor activity and unusual ring structure, pyrroloiminoquinone alkaloid synthesis has attracted the interest of many organic chemists, and over the last decade, the total synthesis of a few of them as well as synthetic approaches has appeared. Our group accomplished the first total syntheses of discorhabdin C (7) [37], makaluvamine F [38,39] and discorhabdin A (1) [40–43]. In 2009, we also accomplished the first total synthesis of prianosin B (2) [44]. In this review, we describe the total syntheses of the discorhabdins by various chemists to-date.

2. Studies of the Total Synthesis of Discorhabdin C

In 1986, discorhabdin C (7) was isolated from the sponge Latrunculia in New Zealand by Munro et al. and was found to exhibit a strong cytotoxicity against tumor cells (ED50 = 30 ng/mL against P388 and <100 ng/mL against L1210) [45]. Discorhabdin C was the first isolated of the discorhabdins and much attention has been paid to the total synthesis of this attractive target.

2.1. Our Synthesis [37]

The problems in the synthesis of discorhabdin C are the construction of highly fused ring systems and the formation of the indoloquinone imine moiety. An overview of our approaches to the synthesis of discorhabdin C is illustrated in Scheme 1. One approach involves the imine formation between the tryptamine amine of the side chain and the indoloquinone carbonyl as the final step of the synthesis (route a). Another approach involves the oxidative coupling of the indoloquinone imine by phenyliodine bistrifluoroacetate (PIFA) as the final step (route b) [46].
A reasonable starting material for route a is 2-hydroxy-4-methoxybenzaldehyde (17). The benzylation of 17 with BnBr and K2CO3 followed by condensation with ethyl azidoacetate (N3CH2CO2Et) in ethanolic sodium ethoxide gave the vinyl azide, which was decomposed in boiling xylene to give the 2-(ethoxycarbonyl)indole (18) in 73% yield over three steps. Hydrolysis of the ester group of 18 with KOH gave indolecarboxylic acid, which was decarboxylated with copper chromite under thermal conditions to give the 4,6-disubstituted indole (19). The treatment of the indole 19 with dimethyl(methylene)ammonium iodide (CH2=N+Me2I−) gave the 3-(dimethylamino)methyl derivative. The dimethylamino group was replaced by a cyano group using NaCN via the quaternary salt to yield the 3-(cyanomethyl)indole (20). Catalytic hydrogenation of the cyano group of 20 with Raney Ni followed by protection of the resulting amino group with the trifluoroacetyl or the [(trimethylsilyl)ethoxy]carbonyl (Teoc) groups afforded 21a (R = COCF3) and 21b (R = Teoc), respectively. Debenzylation of 21a,b with reduction followed by oxidation using Fremy’s salt gave the corresponding quinones (22a,b). The treatment of 22a,b with 3,5-debromotyramine hydrobromide gave the phenol derivatives (23a,b). Silylation of 23a,b with o-silylated ketene acetal (MeCH=C(OMe)(OSiMe3)) followed by oxidation with PIFA resulted in the desired intermediate (15a,b). Unfortunately, all attempts to effect the final imine formation between the tryptamine nitrogen and the indoloquinone carbonyl in these types of intermediates failed (Scheme 2).
An alternative approach (route b), in which phenolic coupling of the previously produced aminoindoloquinone imine (16) is employed in the final step, accomplished the first total synthesis of discorhabdin C (7). The direct imine formation from the indoloquinone was achieved by protection of the indoloquinone nitrogen with the tosyl group followed by an acidic dehydrative treatment. The treatment of 22b with p-toluenesulfonyl chloride gave the N-tosylate (24). Deprotection of the Teoc group of 24 with anhydrous p-toluenesulfonic acid in acetonitrile in the presence of 3Å molecular sieves and sodium bicarbonate yielded an unstable indoloquinone imine (25), which was subjected to the following one-pot transformation without further purification. When treated with 3,5-dibromotyramine hydrobromide in ethanol, the indoloquinone imine underwent a facile substitution reaction and subsequent detosylation to give the phenolic aminoindoloquinone imine (16). The conversion of 16 into its corresponding silylether and the subsequent oxidative coupling reaction using PIFA gave rise to discorhabdin C (7) (Scheme 3).
This efficient route was used for the synthesis of a wide variety of previously inaccessible sulfur-containing discorhabdin and prianosin alkaloids (vide infra).

2.2. Yamamura’s Synthesis [47,48]

At the same time as our report, Yamamura et al. also reported the total synthesis of discorhabdin C (7). Their synthesis was initiated from the conversion of the known nitrobenzaldehyde (26) into the corresponding amide compound (27) in a two-step procedure: reduction of the nitro group followed by Z protection of the generated amine. Manipulation of 27 involving the Curtius reaction provided the diaminobenzene, whose two amino functions could be differentiated by the diverse protection groups (Teoc and Z). Thus, after reductive removal of the benzyloxycarbonyl group, the generated amine was benzylated in the usual manner to give 29. Among a variety of methods for indole-skeleton constructions, they chose the reaction of 29 with ethyl 4-chloroacetoacetate, which gave rise to the simultaneous introduction of a C2 unit at the C-3 position of the indole (30). Access to the tetrahydropyrroloquinoline (32) was effected by Gannortt’s procedure, i.e., the stepwise removal of the amino and carboxylic acid protective groups of 30 followed by lactam formation provided the tricyclic product (31) in a good overall yield. The amide function of 31 was reduced with BH3·SMe2, and the resulting amine was oxidized with CAN (ceric ammonium nitrate) to produce the expected tetrahydropyrroloquinoline (32) in two steps, which further underwent a nucleophilic substitution reaction with 3,5-dibromotyramine to furnish 33 in 78% yield. The electrolysis of bromophenol (33) furnished the expected benzyldiscorhabdin C (34) accompanied by the ring-expanded product (35) (Scheme 4).
Unfortunately, in the last step, all efforts made to remove the benzyl protective group of 34 were unsuccessful. Therefore, they synthesized the bromophenol derivative (16). The indole (30) was hydrogenated under acidic conditions to remove the benzyl and Teoc protective groups, and the succeeding lactamization as in the case of 30 yielded 36. The conversion of 36 into 16 smoothly proceeded according to the procedure for the synthesis of 33. Upon anodic oxidation, 16 produced the desired discorhabdin C (7) in 24% yield accompanied by the ring-expanded product (37) in 6% yield (Scheme 5).

2.3. Heathcock’s Synthesis [49]

In 1999, Heathcock et al. accomplished the total synthesis of discorhabdin C (7) by a phenolic coupling reaction with cupric chloride. 2-Nitroguaiacol (38) was chosen as the starting material. The benzylation of the phenolic hydroxyl group and reduction of the nitro group with Fe and HCl gave the corresponding amino compound, which underwent regioselective iodination with ICl to provide the ortho-iodo derivative 39. The Heck reaction of 39 with Pd(OAc)2 and (o-tol)3P yielded an indole (40), which was followed by reduction with LiAlH4, and protection with Boc and Ts to provide the 7-benzyloxy-1-tosyl compound (41). The debenzylation of 41 with H2 and Pd/C afforded the 7-hydroxyindole (42), of which treatment with Fremy’s salt gave the para-quinone (43). The deprotection of 43 with TFA (CF3CO2H) produced the indoloquinoneimine (25). The imine (25) underwent a nucleophilic substitution reaction with 3,5-dibromotyramine to furnish 44. The treatment of 44 with three equivalents of CuCl2 and four equivalents of Et3N under O2 bubbling gave N-tosyldiscorhabdin C (45), of which the detosylation with NaOMe resulted in the formation of the expected discorhabdin C (7) (Scheme 6).
Heathcock et al. also achieved the total synthesis of (±)-discorhabdin E (8) [49]. The imine (25) underwent a nucleophilic substitution reaction with o-bromotyramine to furnish 46. The treatment of 46 with three equivalents of CuCl2 and four equivalents of Et3N under O2 bubbling gave N-tosyldiscorhabdin E (47), the detosylation of which with NaOMe resulted in the formation of the expected (±)-discorhabdin E (8).

3. Studies of the Total Synthesis of Sulfur-Containing Makaluvamine, Makaluvamine F (48) [38,39]

Among the makaluvamines, makaluvamine F (48) has the most potent biological activities (e.g., cytotoxicity towards the human colon tumor cell line HCT-116 (IC50 = 0.17 μM) and inhibition of topoisomerase II). Makaluvamine F (48) has an α-aminodihydrobenzothiophene skeleton, which is a labile N,S-acetal structure present in all sulfur-containing discorhabdins. Synthetic studies of the makaluvamines and discorhabdins have been carried out by several groups. However, in most cases, these efforts have been devoted only to the diverse preparations of the pyrroloiminoquinone and spirodienone units. To the best of our knowledge, the total syntheses of the sulfur-containing discorhabdins and makaluvamine F had not been reported until our synthesis, despite their potent cytotoxicity and their unique structure. This is probably due to the difficulty in construction of the labile and highly strained N,S-acetal skeletons. In our efforts to synthesize the discorhabdin alkaloids, we succeeded in the total synthesis of discorhabdin C (7) using the PIFA-mediated spirocyclization reaction. Thus, the remaining challenge for the total syntheses of these targets (the sulfur-containing family) was the construction of the labile and highly strained N,S-acetal skeletons. Our synthetic strategy for the total synthesis of makaluvamine F (48) is shown in Scheme 8.

3.1. Facile and Direct Synthesis of the Pyrroloiminoquinone Unit [50]

We found that the treatment of phenyl ethers with an alkylazido group (49) in the presence of PIFA-TMSOTf in (CF3)2CHOH-ROH or CF3CH2OH-ROH gave the corresponding quinone imine dimethylacetals (50), which in (CF3)3CHOH-H2O or CF3CH2OH-H2O gave the corresponding quinine imines (51) [51] (Scheme 9). Quinone imines and quinone imine monoacetals have been proposed as the intermediates in a number of biological processes. Quinone imines were also found in the structure of marine alkaloids.
We have developed a facile and direct preparation of the quinone imine derivatives, and very recently reported the synthesis of pyrroloiminoquinones from the indole bearing an alkylazido group [52]. The starting substrate was prepared as follows. The treatment of 6,7-dimethoxyindole (52) with oxalyl chloride followed by LAH reduction gave 3-(hydroxyethyl)indole (53) (95% yield), which was converted to 3-(azidoethyl)indole (55) via 3-(iodoethyl)indole (54) in 65% yield. The N-protected 3-(azidoethyl)indoles (56a–f) were readily prepared from 55 by standard alkylation and acylation methods. First, we examined the reaction of 55 with PIFA-TMSOTf, but only a complex mixture was obtained. The reactions of 56a (R = Me) and 56b (R = Si(i-Pr)3) with PIFA-Me3SiOTf also gave complex mixtures, probably due to the side reactions occurring at the 1- or 3-position on the indole nucleus. In fact, several groups have already reported that a 1-, 2- or 3-substituted indole derivative is obtained from the reaction of indoles with iodobenzene diacetate. Therefore, we examined the reactions of the 1-protected indoles (56c–f) with PIFA-Me3SiOTf in the presence of H2O. We found that the corresponding N-deprotected pyrroloiminoquinones (57) or the N-protected pyrroloiminoquinones (25 and 58) were obtained in moderate yields when the indoles protected with an electron-withdrawing group, such as the acetyl, benzoyl, tosyl or benzyloxycarbonyl group, were treated with PIFA-Me3SiOTf in (CF3)2CHOH-H2O (50:1) (Scheme 10).

3.2. Synthesis of the Dihydrothiophene Units [52,53]

In our previous studies, we developed the direct sulfenylation of phenyl ethers using PIFA [54,55]. Furthermore, we developed the intramolecular cyclization of phenyl ethers (59) bearing an alkylsulfide group using PIFA in (CF3)2CHOH and PIFA-BF3·Et2O in CH2Cl2 that specifically produced the corresponding sulfur-containing heterocycles (60) (Scheme 11) [52].
A plausible reaction mechanism is that the electron-rich aromatic ring is initially oxidized by the activated PIFA via a single electron transfer (SET), and then the sidechain attacks the radical cation. Although other mechanisms, such as the one via the sulfonium salt could also be possible, we proposed the mechanism via the radical cation (Scheme 12).
We constructed the dihydrobenzothiophenes using the direct sulfenylation of phenol ethers with PIFA and arylthiols. The synthesis was initiated from the methyl 4-hydroxyphenylacetate (61) to afford the phenol ether (63) bearing an alkyl sulfide side chain in five steps. The treatment of the phenol ether (63) with PIFA-BF3·Et2O followed by the treatment of aqueous MeNH2 provided the dihydrobenzothiophenes (64) (Scheme 13).
Next, we attempted to synthesize the α-azidodihydrobenzothiophenes, which can serve as an N,S-acetal equivalent, by the introduction of an azido group to the dihydrobenzothiophene derivatives. After considerable effort, we found a novel and direct α-azidation method for cyclic sulfides using a combination of PhI=O and Me3SiN3 (Scheme 14) [53]. A plausible reaction mechanism is proposed in Scheme 15. The sulfonium cation (66) initially formed by the reaction of the sulfide with PhI=O-Me3SiN3, whose combination was studied by Magnus and co-workers, is then deprotonated to give a cation intermediate (67). The azido anion attacks the α-position of 67 to produce the α-azido sulfide (65).
Although azidation of 5-bromo-6-benzyloxydihydrobenzothiophene (70) gave only a trace amount of the expected α-azido compound, treatment of the acetylated compound (71) with PhI=O and Me3SiN3 followed by hydrolytic deprotection of the 6-acetoxy group provided the 2-azido-5-bromo-6-hydroxydihydrobenzothiophene (72) (Scheme 16).

3.3. Total Synthesis of (±)-Makaluvamine F (48) [38,39]

Catalytic hydrogenation of 72 followed by the coupling reaction with 57 in MeOH in the presence of Me3SiOTf gave makaluvamine F only in a poor yield. Finally, we found that the catalytic hydrogenation of 72 using 10% Pd-C in the presence of four equivalents of trifluoroacetic acid (TFA) resulted in complete reduction leading to a TFA salt in quantitative yield without any side reactions. The final coupling reaction in MeOH between both synthetic precursors, the TFA salt and 57, proceeded to give the TFA salt of makaluvamine F (48) (Scheme 17).

4. Total Synthesis of Discorhabdin A [40–43]

In 1987, prianosin A [28] was isolated from the Okinawan sponge Prianos melanos by Kobayashi et al., and in 1988, discorhabdin A [29] was isolated from New Zealand sponges of the genus Latrunculia by Munro et al. Some years later, it was found that prianosin A and discorhabdin A were the same compound. Discorhabdin A (prianosin A) is antimicrobial and has a strong cytotoxicity (IC50 values of 37 ng/mL, 14 ng/mL, 40 ng/mL and 13 ng/mL against L1210, L5178Y, P388 and xrs-6 in vitro, respectively, and ED50 values of 50 ng/mL against P388). Our next synthetic target was discorhabdin A (1), which has a unique sulfur-containing fused ring system incorporating azacarbocyclic spirocyclohexanone and pyrroloiminoquinone systems, and shows the most powerful cytotoxic activity among the isolated discorhabdins.
First, on the basis of the hypothesis by Munro and co-workers [56], we examined the biosynthetically plausible route from makaluvamine F (48) using our previously developed oxidative spirocyclization reaction with PIFA. As a result, the oxidative cyclization of makaluvamine F (48) as well as the trimethylsilylated makaluvamine F using PIFA under various conditions yielded a complex mixture, probably due to the high reactivity of the iodine(III) reagent toward the sulfide group, the aminoiminoquinone skeleton, and the phenolic OH group in makaluvamine F (48) (Scheme 18).
Therefore, we altered the synthetic strategy. The new strategy included the pre-construction of the spirodienone system using the hypervalent iodine(III) reagent and the final introduction of the sulfur group to the cross-linked system. We first examined the shorter path via an amino acid derivative. The tritylation of the l-tyrosine methyl ester hydrochloride (73) with TrCl and Et3N followed by mono-bromination with NBS yielded 74 (two steps, 65% yield). The coupling reaction of 74 with pyrroloiminoquinone 25, which was prepared by our previously developed PIFA-induced pyrroloiminoquinone formation, provided 75 as its CF3CO2H salt (75·TFA). We then examined the oxidative spirocyclization reaction of 75·TFA using PIFA. Although the various reaction conditions tested, this reaction did not give the corresponding spirodienone, but yielded a complex mixture; probably because generation of the free base of 75 was difficult. This might be because 75·TFA has an active methine proton and readily decomposed under basic conditions (even in the presence of Et3N). Thus, we modified the synthetic strategy using an alternative route via the amino alcohol as follows: reduction of 74 with DIBAH followed by silylation of the resulting alcohol with TBSCl gave the bis-silylated compound 76, and a coupling reaction with pyrroloiminoquinone 25 yielded 77. The spirodienone formation of 77 using PIFA effectively proceeded in the presence of MK10 to give a diastereomeric mixture of 78 and 78′. Both diastereomers were readily separated by column chromatography on silica gel to give the less polar isomer 78 and the polar isomer 78′ (Scheme 19).
The major isomer 78, whose absolute stereochemistry (S configuration) of the spirocenter (C-6) is the same as that of natural discorhabdin A (1), was desilylated by BF3·Et2O, and then converted into the N,O-acetal intermediate 79 by an oxidative fragmentation reaction with C6F5I(OCOCF3)2 and MeOH. The p-methoxybenzylthio group was efficiently introduced in the presence of BF3·Et2O to give the unstable N,S-acetal A as a diastereomeric mixture. The debenzylation of A, a labile and highly functionalized compound, also required the mildest possible reaction conditions. Our initial strategy was to perform a mild debenzylation on the p-methoxybenzylsulfonium salt formed by the 1,4-addition of a sulfide group to the cyclohexadienone moiety. Accordingly, we treated a diastereomeric mixture of A with 30% HBr-AcOH followed by aqueous work up with MeNH2 that produced the N-tosylated discorhabdin A (80). Ultimately, we developed an efficient one-pot transformation procedure yielding 80 from 79. The procedure using p-methoxybenzylthiol in 30% HBr-AcOH (36 h; −78~4 °C) followed by treatment with aqueous MeNH2 mainly gave 80: the enantiomeric excess (ee) of 80 was confirmed to be >99% by HPLC analysis using a chiral column (DAICEL CHIRALCEL OD; n-Hex/i-PrOH = 65/35; 20 °C). Finally, removal of the tosyl group of 80 with NaOMe in THF gave discorhabdin A (1) in the optically pure form for the first time (Scheme 20. The synthetic product as its HCl salt was identical in all respects with the natural discorhabdin A including its optical rotation {synthetic discorhabdin A: [α]D +388 (c = 0.06, MeOH); natural discorhabdin A: [α]D +400 (c = 0.05, MeOH)} and 1H NMR nOe data.
Furthermore, we also completed the total synthesis of the unnatural discorhabdin A, (−)-discorhabdin A, starting from the d-tyrosine methyl ester by the same route as described for (+)-discorhabdin A (1) {synthetic product: [α]D -390 (c = 0.05, MeOH)}.

5. Semi-Synthesis of Discorhabdins P and U [57]

In 2006, Copp et al. reported the semi-synthetic preparation of discorhabdins P (81) and U (13) from natural discorhabdins C (7) and B (4). In New Zealand waters, Latrunculia sp. sponges are a rich source of the discorhabdin alkaloids, with organisms capable of producing either discorhabdins A (1), B (4) or C (7) as their major secondary metabolites, typically in isolated yields of 25–35 mg/g dry sponge weight [58]. The aim of the Copp et al. study was to investigate the methylation of discorhabdin C (7) in an effort to prepare discorhabdin P (81) or related N-methyl analogs for further biological testing, and for the first time, to prepare similar analogs of discorhabdin B (4) in an effort to expand the structure-activity relationship understanding of this class of compounds. Discorhabdin C (7) was reacted with CH3I in dry acetone to yield a single major product, the 13-N-methyl analog discorhabdin P (81) in 54% yield (Scheme 21). Discorhabdin B (4) was reacted with CH3I in dry acetone to yield two products, discorhabdin U (13) and 82. The products of this reaction were dependent upon the molar equivalents of CH3I used: with a large excess (10–25 equivalent) yielding predominantly discorhabdin U (13), while a two molar equivalent of CH3I yielded the mono-methyl 82. The order of the methylation of discorhabdin B (4) preferentially favors the thio group and a large excess of CH3I enables the methylation at the N-13 pyrrole position.

6. Total Synthesis of Prianosin B [44]

Although, some 20 years ago, Kobayashi et al. also reported one such family, prianosin B (2), which has the 16,17-dehydropyrroloiminoquinone structure, its synthesis has not yet been reported [17]. For the synthesis of prianosin B (2), the construction of the 16,17-dehydropyrroloiminoquinone structure is an important issue. We have succeeded in the first total synthesis of the sulfur-containing discorhabdin, discorhabdin A [40–43]. We postulated that the prianosins and discorhabdins with the 16,17-dehydropyrroloiminoquinone moiety can be synthesized by dehydrogenation of the pyrroloiminoquinone of the discorhabdin A (1) or discorhabdin A intermediate (Scheme 22).
We first examined the dehydrogenation reaction of the simple spirodienone (83) with various oxidants as the model reaction. However, reactions with oxidants, such as DDQ, CAN, MnO2 and Pd/C (Yamamura’s conditions) [59], gave poor results (Scheme 23).
We next tried the use of nucleophiles, because White et al. reported that the dehydrogenation and detosylation of the pyrroloiminoquinone system using sodium azide as a nucleophile [60]. From a detailed study of nucleophiles, we found that the use of a catalytic amount of NaN3 produced the best result. Since it was revealed that the detosylation and dehydrogenation reaction of the pyrroloiminoquinone unit with a catalytic amount of NaN3 proceeded in good yield, the total synthesis of prianosin B (2) was next studied (Scheme 24). In our own total synthesis of discorhabdin A (1), the N,O-acetal intermediate (79) was prepared from the l-tyrosine methyl ester hydrochloride in eight steps. The sulfur cross linkage reaction of the intermediate was carried out using p-MeOBnSH and 30% HBr-AcOH followed by aqueous MeNH2 to give the sulfur-linked pyrroloiminoquinone compound 80. The treatment of 80 with NaN3 in DMF caused detosylation and dehydrogenation to produce prianosin B (2) in 48% yield. The spectral data were identical to that reported for the natural prianosin B (2) ([α]23D +362 (c 0.405, CHCl3), lit. [α]30D +360 (c 0.1, CHCl3) [17]).
For determining the reaction mechanism, two studies were carried out. One was the measurement of the mass spectrum of the reaction mixture. A suspension of spirodienone 83 and NaN3 in DMF was stirred under nitrogen at 70 °C for 40 min. The mass spectrum of the reaction mixture revealed the ion peak of TsN3. The other was the reaction of the N-H spirodienone 85 and TsN3 under basic conditions. Thus, NaH and TsN3 were added to a solution of 85 in DMF and the aromatic compound 86 was obtained in 41% yield (Scheme 25).
A plausible reaction mechanism for the present dehydrogenation reaction of pyrroloiminoquinone using NaN3 is illustrated in Scheme 26. It would involve the nucleophilic attack of N3− on the tosyl residue followed by the addition of metalo enamine to TsN3 to produce the intermediate I [61–63]. Dehydrogenation would proceed by the intramolecular elimination via a six-membered transition state to produce the intermediate III and isomerization to produce 86 [64–65]. Reproduction of the azide anion during the reaction would make possible the use of the catalytic amount of NaN3. The reproduction of the azide anion was deduced from the presence of toluenesulfinic acid observed in the 1H-NMR spectrum (Scheme 26).

7. Summary

In this review, we described the existing studies on the total synthesis of the discorhabdins. Because of their prominent potent antitumor activity and unusual ring structure, synthesis of the discorhabdins has attracted the interests of many organic chemists. Many synthetic approaches have appeared over the past decade, however, only few discorhabdins have been completely synthesized. We have accomplished the total syntheses of discorhabdins C, A and prianosin B. Discorhabdin A has the strongest activity in vitro, but no activity in vivo. Therefore, we are synthesizing a variety of discorhabdin analogs [66]. Although many synthetic studies of the discorhabdin alkaloids have already appeared, biological studies including structure activity relationship or the mode of action of the discorhabdins have not yet significantly occurred [67–71]. In the next stage, it is necessary to study the structure activity relationship and the mode of action of the discorhabdins.
  • Samples Availability: Available from the authors.

References and Notes

  1. Carté, BK. Biomedical potential of marine natural products. BioScience 1996, 46, 271–285. [Google Scholar]
  2. Faulkner, DJ. Biomedical Uses for Natural Marine Chemicals. Oceanus 1992, 35, 29–35. [Google Scholar]
  3. Faulkner, DJ. Marine natural products: metabolites of marine algae and herbivorous marine mollusks. Nat Prod Rep 1984, 1, 251–280. [Google Scholar]
  4. Barasch, D. Fishing for Drugs. Am Health 1990, 9, 20–21. [Google Scholar]
  5. Cohen, T. Pharmaceuticals from the sea. Technol Rev 1993, 96, 15–16. [Google Scholar]
  6. Liu, R; Cui, C; Duan, L; Gu, Q; Zhu, W. Potent in vitro anticancer activity of metacycloprodigiosin and undecylprodigiosin from a sponge-derived actinomycete Saccharopolyspora sp. nov. Archives of Pharm Res 2005, 28, 1341–1344. [Google Scholar]
  7. Jeong, SY; Ishida, K; Ito, Y; Okada, S; Murakami, M. Bacillamide, a novel algicide from the marine bacterium, Bacillus sp. SY-1, against the harmful dinoflagellate Cochlodinium polykrikoides. Tetrahedron Lett 2003, 44, 8005–8007. [Google Scholar]
  8. Xin, ZH; Zhu, WM; Gu, QQ; Fang, YC; Duan, L; Cui, CB. A new cytotoxic compound from Penicillium auratiogriseum, symbiotic or epiphytic fungus of sponge Mycale plumose. Chin Chem Lett 2005, 16, 1227–1229. [Google Scholar]
  9. Xin, Z; Tian, L; Zhu, T; Wang, W; Du, L; Fang, Y; Gu, Q; Zhu, W. Isocoumarin derivatives from the sea squirt-derived fungus Penicillium stoloniferum QY2-10 and the halotolerant fungus Penicillium notatum B-52. Arch Pharm Res 2007, 30, 816–819. [Google Scholar]
  10. Wang, F; Fang, Y; Zhang, M; Lin, A; Zhu, T; Gu, Q; Zhu, W. Six new ergosterols from the marine-derived fungus Rhizopus sp. Steroids 2008, 73, 19–26. [Google Scholar]
  11. Wang, F; Fang, Y; Zhu, T; Zhang, M; Lin, A; Gu, Q; Zhu, W. Seven new prenylated indole diketopiperazine alkaloids from holothurianderived fungus Aspergillus fumigatus. Tetrahedron 2008, 64, 7986–7991. [Google Scholar]
  12. Urban, S; Hickford, SJH; Blunt, JW; Munro, MHG. Bioactive Marine Alkaloids. Curr Org Chem 2000, 4, 765–805. [Google Scholar]
  13. Gunasekera, SP; Zuleta, IA; Longley, RE; Wright, AE; Pomponi, SA. Discorhabdins S, T, and U, New Cytotoxic Pyrroloiminoquinones from a Deep-Water Caribbean Sponge of the Genus Batzella. J Nat Prod 2003, 66, 1615–1617. [Google Scholar]
  14. Reyes, F; Martin, R; Rueda, A; Fernandez, R; Montalvo, D; Gomez, C; Sanchez-Puelles, JM. Discorhabdins I and L, Cytotoxic Alkaloids from the Sponge Latrunculia brevis. J Nat Prod 2004, 67, 463–465. [Google Scholar]
  15. Antunes, EM; Beukes, DR; Kelly, M; Samaai, T; Barrows, LR; Marshall, KM; Sincich, C; Davies-Coleman, MT. Cytotoxic Pyrroloiminoquinones from Four New Species of South African Latrunculid Sponges. J Nat Prod 2004, 67, 1268–1276. [Google Scholar]
  16. Harayama, Y; Kita, Y. Pyrroloiminoquinone alkaloids. Discorhabdins and makaluvamines. Curr Org Chem 2005, 9, 1567–1588. [Google Scholar]
  17. Cheng, J; Ohizumi, Y; Wälchli, MR; Nakamura, H; Hirata, Y; Sasaki, T; Kobayashi, J. Prianosins B, C, and D, novel sulfur-containing alkaloids with potent antineoplastic activity from the Okinawan marine sponge Prianos melanos. J Org Chem 1988, 53, 4621–4624. [Google Scholar]
  18. Monks, A; Scuderio, DA; Skehan, P; Shoemaker, RH; Paull, KD; Hose, VC; Langley, J; Cronise, P; Vaigro-Wolff, A; Grey-Goodrich, M; Campball, H; Boyd, MR. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J Natl Cancer Inst 1991, 83, 757–766. [Google Scholar]
  19. Carney, JR; Scheuer, PJ; Kelly-Borges, M. Makaluvamine G, a cytotoxic pigment from an an Indonesian Sponge Histodermella sp. Tetrahedron 1993, 49, 8483–8486. [Google Scholar]
  20. Schmidt, EW; Harper, MK; Faulkner, DJ. Makaluvamines H-M and Damirone C from the Pohnpeian Sponge Zyzzya fuliginosa. J Nat Prod 1995, 58, 1861–1867. [Google Scholar]
  21. Venables, DA; Concepción, GP; Matsumoto, S; Barrows, LR; Ireland, CM. Makaluvamine N: A New Pyrroloiminoquinone from Zyzzya fuliginosa. J Nat Prod 1997, 60, 408–410. [Google Scholar]
  22. Sun, HH; Sakemi, S; Burres, N; McCarthy, P. Isobatzellines A, B, C, and D. Cytotoxic and antifungal pyrroloquinoline alkaloids from the marine sponge Batzella sp. J Org Chem 1990, 55, 4964–4966. [Google Scholar]
  23. Gunasekera, SP; McCarthy, PJ; Longley, RE; Pomponi, SA; Wright, AE. Secobatzellines A and B, Two New Enzyme Inhibitors from a Deep-Water Caribbean Sponge of the Genus Batzella. J Nat Prod 1999, 62, 1208–1211. [Google Scholar]
  24. Copp, BR; Ireland, CM. Wakayin: A Novel Cytotoxic Pyrroloiminoquinone Alkaloid from the Ascidian Clavelina Species. J Org Chem 1991, 56, 4596–4597. [Google Scholar]
  25. Stierle, DB; Faulkner, DJ. Two New Pyrroloquinoline Alkaloids from the Sponge Damiria sp. J Nat Prod 1991, 54, 1131–1133. [Google Scholar]
  26. Schmidt, EW; Harper, MK; Faulkner, DJ. Makaluvamines H-M and Damirone C from the Pohnpeian Sponge Zyzzya Fuliginosa. J Nat Prod 1995, 58, 1861–1867. [Google Scholar]
  27. Delfourne, E. Analogues of Marine Pyrroloiminoquinone Alkaloids: Synthesis and Antitumore Properties. Anti-Cancer Agents Med Chem 2008, 8, 910–916. [Google Scholar]
  28. Kobayashi, J; Cheng, JF; Ishibashi, M; Nakamura, H; Ohizumi, Y; Hirata, Y; Sasaki, T; Lu, H; Clardy, J. Prianosin A, a novel antileukemic alkaloid from the okinawan marine sponge Prianos melanos. Tetrahedron Lett 1987, 28, 4939–4942. [Google Scholar]
  29. Perry, NB; Blunt, JW; Munro, MHG. Cytotoxic pigments from new zealand sponges of the genus latrunculia: discorhabdins A, B and C. Tetrahedron 1988, 44, 1727–1734. [Google Scholar]
  30. Perry, NB; Blunt, JW; Munro, MHG. Discorhabdin D, an antitumor alkaloid from the sponges Latrunculia brevis and Prianos sp. J Org Chem 1988, 53, 4127–4128. [Google Scholar]
  31. Dijoux, MG; Gamble, WR; Hallock, YF; Cardellina, JH, II; Soest, R; Boyd, MR. A New Discorhabdin from Two Sponge Genera. J Nat Prod 1999, 62, 636–637. [Google Scholar]
  32. Ford, J; Capon, RJ. Discorhabdin R: A New Antibacterial Pyrroloiminoquinone from Two Latrunculiid Marine Sponges, Latrunculia sp. and Negombata sp. J Nat Prod 2000, 63, 1527–1528. [Google Scholar]
  33. El-Naggar, M; Capon, RJ. Discorhabdins Revisited: Cytotoxic Alkaloids from Southern Australian Marine Sponges of the Genera Higginsia and Spongosorites. J Nat Prod 2009, 72, 460–464. [Google Scholar]
  34. Cheng, J; Ohizumi, Y; Wälchli, MR; Nakamura, H; Hirata, Y; Sasaki, T; Kobayashi, J. Prianosins B, C, and D, novel sulfur-containing alkaloids with potent antineoplastic activity from the Okinawan marine sponge Prianos melanos. J Org Chem 1988, 53, 4621–4624. [Google Scholar]
  35. Lang, G; Pinkert, A; Blunt, JW; Munro, MHG. Discorhabdin W, the First Dimeric Discorhabdin. J Nat Prod 2005, 68, 1796–1798. [Google Scholar]
  36. Blunt, JW; Munro, MHG; Battershill, CN; Copp, BR; McCombs, JD; Perry, NB; Prinsep, M; Thompson, AM. From the Antarctic to the Antipodes; 45° of marine chemistry. New J Chem 1990, 14, 761–775. [Google Scholar]
  37. Kita, Y; Tohma, H; Inagaki, M; Hatanaka, K; Yakura, T. Total synthesis of discorhabdin C: a general aza spiro dienone formation from O-silylated phenol derivatives using a hypervalent iodine reagent. J Am Chem Soc 1992, 114, 2175–2180. [Google Scholar]
  38. Kita, Y; Egi, M; Tohma, H. Total synthesis of sulfur-containing pyrroloiminoquinone marine product, (±)-makaluvamine F using hypervalent iodine(III)-induced reactions. Chem Commun 1999, 143–144. [Google Scholar]
  39. Kita, Y; Egi, M; Takada, T; Tohma, H. Development of novel reactions using hypervalent iodine(III) reagents. Total synthesis of sulfur-containing pyrroloiminoquinone marine product, (±)-makaluvamine F. Synthesis 1999, 885–897. [Google Scholar]
  40. Tohma, H; Harayama, Y; Hashizume, M; Iwata, M; Egi, M; Kita, Y. Synthetic studies on the sulfur-cross-linked core of antitumor marine alkaloid, discorhabdins: total synthesis of discorhabdin A. Angew Chem Int Ed 2002, 41, 348–350. [Google Scholar]
  41. Tohma, H; Harayama, Y; Hashizume, M; Iwata, M; Kiyono, Y; Egi, M; Kita, Y. The First Total Synthesis of Discorhabdin A. J Am Chem Soc 2003, 125, 11235–11240. [Google Scholar]
  42. Harayama, Y; Yoshida, M; Kamimura, D; Kita, Y. The novel and efficient direct synthesis of N,O-acetal compounds using a hypervalent iodine(III) reagent: an improved synthetic method for a key intermediate of discorhabdins. Chem Commun 2005, 1764–1766. [Google Scholar]
  43. Harayama, Y; Yoshida, M; Kamimura, D; Wada, Y; Kita, Y. The efficient direct synthesis of N,O-acetal compounds as key intermediates of discorhabdin A: oxidative fragmentation reaction of α-amino acids or β-amino alcohols by using hypervalent iodine(III) reagents. Chem Eur J 2006, 12, 4893–4899. [Google Scholar]
  44. Wada, Y; Otani, K; Endo, N; Harayama, Y; Kamimura, D; Yoshida, M; Fujioka, H; Kita, Y. The first total synthesis of prianosin B. Tetrahedron 2009, 65, 1059–1062. [Google Scholar]
  45. Perry, NB; Blunt, JW; McCombs, JD; Munro, MHG. Discorhabdin C, a highly cytotoxic pigment from a sponge of the genus Latrunculia. J Org Chem 1986, 51, 5476–5478. [Google Scholar]
  46. Kita, Y; Yakura, T; Tohma, H; Kikuchi, K; Tamura, Y. A synthetic approach to discorhabdin alkaloids: Hypervalent iodine oxidation of p-substituted phenol derivatives to azacarbocyclic spirodienones. Tetrahedron Lett 1989, 30, 1119–1120. [Google Scholar]
  47. Nishiyama, S; Cheng, JF; Tao, XL; Yamamura, S. Synthetic studies on novel sulfur-containing alkaloids, prianosins and discorhabdins: total synthesis of discorhabdin C. Tetrahedron Lett 1991, 32, 4151–4154. [Google Scholar]
  48. Tao, XL; Cheng, JF; Nishiyama, S; Yamamura, S. Synthetic studies on tetrahydropyrroloquinoline-containing natural products: Syntheses of discorhabdin C, batzelline C and isobatzelline C. Tetahedron 1994, 50, 2017–2028. [Google Scholar]
  49. Aubart, KM; Heathcock, CH. A Biomimetic Approach to the Discorhabdin Alkaloids: Total Syntheses of Discorhabdins C and E and Dethiadiscorhabdin D. J Org Chem 1999, 64, 16–22. [Google Scholar]
  50. Kita, Y; Egi, M; Ohtsubo, M; Saiki, T; Okajima, A; Takada, T; Tohma, H. Hypervalent iodine(III)-induced intramolecular cyclization reaction of substituted phenol ethers with an alkyl azido side-chain: a novel and efficient synthesis of quinone imine derivatives. Chem Pharm Bull 1999, 47, 241–245. [Google Scholar]
  51. Kita, Y; Egi, M; Okajima, A; Ohtsubo, M; Takada, T; Tohma, H. Hypervalent iodine(III) induced intramolecular cyclization of substituted phenol ethers bearing an alkyl azido sidechain-a novel synthesis of quinone imine ketals. Chem Commun 1996, 1491–1492. [Google Scholar]
  52. Kita, Y; Egi, M; Ohtsubo, M; Saiki, T; Takada, T; Tohma, H. Novel and efficient synthesis of sulfur-containing heterocycles using a hypervalent iodine(III) reagent. Chem Commun 1996, 2225–2226. [Google Scholar]
  53. Tohma, H; Egi, M; Ohtsubo, M; Watanabe, H; Takizawa, S; Kita, Y. A novel and direct α-azidation of cyclic sulfides using a hypervalent iodine(III) reagent. Chem Commun 1998, 173–174. [Google Scholar]
  54. Kita, Y; Takada, T; Mihara, S; Tohma, H. A novel and direct sulfenylation of phenol ethers using phenyliodine(III) bis(trifluoroacetate) (PIFA) and various thiophenols. Synlett 1995, 211–212. [Google Scholar]
  55. Kita, Y; Takada, T; Mihara, S; Whelan, BA; Tohma, H. Novel and Direct Nucleophilic Sulfenylation and Thiocyanation of Phenol Ethers Using a Hypervalent Iodine(III) Reagent. J Org Chem 1995, 60, 7144–7148. [Google Scholar]
  56. Lill, RE; Major, DA; Blunt, JW; Munro, MHG. Studies on the Biosynthesis of Discorhabdin B in the New Zealand Sponge Latrunculia sp. B. J Nat Prod 1995, 58, 306–311. [Google Scholar]
  57. Grkovic, T; Kaur, B; Webb, VL; Copp, BR. Semi-synthetic preparation of the rare, cytotoxic, deep-sea sourced sponge metabolites discorhabdins P and U. Bioorg Med Chem Lett 2006, 16, 1944–1946. [Google Scholar]
  58. Miller, K; Alvarez, B; Bettershill, C; Northcote, P; Parthasarathy, H. Genetic, morphological, and chemical divergence in the sponge genus Latrunculia (Porifera: Demospongiae) from New Zealand. Mar Biol 2001, 139, 235–250. [Google Scholar]
  59. Izawa, T; Nishiyama, S; Yamamura, S. Total syntheses of makaluvamines A, B, C, D and E, cytotoxic pyrroloiminoquinone alkaloids isolated from marine sponge bearing inhibitory activities against topoisomerase II. Tetrahedron 1994, 50, 13593–13600. [Google Scholar]
  60. White, JD; Yager, KM; Yakura, T. Synthetic Studies of the Pyrroloquinoline Nucleus of the Makaluvamine Alkaloids. Synthesis of the Topoisomerase II Inhibitor Makaluvamine D. J Am Chem Soc 1994, 116, 1831–1838. [Google Scholar]
  61. Patel, SP; Nadkarni, DH; Murugesan, S; King, JR; Velu, SE. Azide-Mediated Detosylation of N-Tosylpyrroloiminoquinones and N-Tosylindole-4,7-quinones. Synlett 2008, 2864–2868. [Google Scholar]
  62. Regitz, M. Recent synthetic methods in diazo chemistry. Synthesis 1972, 351–373. [Google Scholar]
  63. Evans, DA; Britton, TC. Electrophilic azide transfer to chiral enolates. A general approach to the asymmetric synthesis of .alpha.-amino acids. J Am Chem Soc 1987, 109, 6881–6883. [Google Scholar]
  64. Weil, T; Cais, M. A Simplified Procedure for the Preparation of Diazocyclopentadiene and Some Related Compounds. J Org Chem 1963, 28, 2472. [Google Scholar]
  65. Regitz, M; Liedhegener, A. Reaktionen aktiver methylenverbindungen mit aziden—XV *1: Synthese von diazocyclopentadienen durch diazogruppenübertragung und einige reaktionen. Tetrahedron 1967, 23, 2701–2708. [Google Scholar]
  66. Wada, Y; Otani, K; Endo, N; Harayama, Y; Kamimura, D; Yoshida, M; Fujioka, H; Kita, Y. Synthesis of Antitumor Marine Alkaloid Discorhabdin A Oxa Analogues. Org Lett 2009, 11, 4048–4050. [Google Scholar]
  67. Radisky, DC; Radisky, ES; Barrows, LR; Copp, BR; Kramer, RA; Ireland, CM. Novel cytotoxic topoisomerase II inhibiting pyrroloiminoquinones from Fijian sponges of the genus Zyzzya. J Am Chem Soc 1993, 115, 1632–1638. [Google Scholar]
  68. Dijoux, M-G; Schnabel, PC; Hallock, YF; Boswell, JL; Johnson, TR; Wilson, JA; Ireland, CM; Soest, R; Boyd, MR; Barrows, LR; Cardellina, JH. Antitumor activity and distribution of pyrroloiminoquinones in the sponge genus. Zyzzya Bioorg Med Chem 2005, 13, 6035–6044. [Google Scholar]
  69. Shinkre, BA; Raisch, KP; Fan, L; Velu, SE. Analogs of the marine alkaloid makaluvamines: Synthesis, topoisomerase II inhibition, and anticancer activity. Bioorg Med Chem Lett 2007, 17, 2890–2893. [Google Scholar]
  70. Passarella, D; Belinghieri, F; Scarpellini, M; Pratesi, G; Zunino, F; Gia, OM; Via, LD; Santoro, G; Danieli, B. Analogs of the marine alkaloid makaluvamines: Synthesis, topoisomerase II inhibition, and anticancer activity. Bioorg Med Chem 2008, 16, 2431–2438. [Google Scholar]
  71. Shinkre, BA; Raisch, KP; Fan, L; Velu, SE. Synthesis and antiproliferative activity of benzyl and phenethyl analogs of makaluvamines. Bioorg Med Chem 2008, 16, 2541–2549. [Google Scholar]
Marinedrugs 08 01394f1 1024
Figure 1. The structure of discorhabdin alkaloids.
Figure 1. The structure of discorhabdin alkaloids.
Marinedrugs 08 01394f1
Marinedrugs 08 01394f2 1024
Scheme 1. Retrosynthetic analysis for discorhabdin C.
Scheme 1. Retrosynthetic analysis for discorhabdin C.
Marinedrugs 08 01394f2
Marinedrugs 08 01394f3 1024
Scheme 2. The synthetic approach toward discorhabdin C via route a.
Scheme 2. The synthetic approach toward discorhabdin C via route a.
Marinedrugs 08 01394f3
Marinedrugs 08 01394f4 1024
Scheme 3. The total synthesis of discorhabdin C via route b.
Scheme 3. The total synthesis of discorhabdin C via route b.
Marinedrugs 08 01394f4
Marinedrugs 08 01394f5 1024
Scheme 4. The synthesis of benzyldiscorhabdin C by Yamamura et al.
Scheme 4. The synthesis of benzyldiscorhabdin C by Yamamura et al.
Marinedrugs 08 01394f5
Marinedrugs 08 01394f6 1024
Scheme 5. The total synthesis of discorhabdin C by Yamamura et al.
Scheme 5. The total synthesis of discorhabdin C by Yamamura et al.
Marinedrugs 08 01394f6
Marinedrugs 08 01394f7 1024
Scheme 6. The total synthesis of discorhabdin C by Heathcock et al.
Scheme 6. The total synthesis of discorhabdin C by Heathcock et al.
Marinedrugs 08 01394f7
Marinedrugs 08 01394f8 1024
Scheme 7. The total synthesis of (±)-discorhabdin E by Heathcock et al.
Scheme 7. The total synthesis of (±)-discorhabdin E by Heathcock et al.
Marinedrugs 08 01394f8
Marinedrugs 08 01394f9 1024
Scheme 8. Retrosynthetic analysis of makaluvamine F (48).
Scheme 8. Retrosynthetic analysis of makaluvamine F (48).
Marinedrugs 08 01394f9
Marinedrugs 08 01394f10 1024
Scheme 9. Intramolecular cyclization of phenylethers bearing an alkylazido group.
Scheme 9. Intramolecular cyclization of phenylethers bearing an alkylazido group.
Marinedrugs 08 01394f10
Marinedrugs 08 01394f11 1024
Scheme 10. A novel synthetic method for pyrroloiminoquinones.
Scheme 10. A novel synthetic method for pyrroloiminoquinones.
Marinedrugs 08 01394f11
Marinedrugs 08 01394f12 1024
Scheme 11. Intramolecular cyclization of phenylethers bearing an alkyl sulfide group.
Scheme 11. Intramolecular cyclization of phenylethers bearing an alkyl sulfide group.
Marinedrugs 08 01394f12
Marinedrugs 08 01394f13 1024
Scheme 12. A plausible mechanism for the cyclization reaction of 59.
Scheme 12. A plausible mechanism for the cyclization reaction of 59.
Marinedrugs 08 01394f13
Marinedrugs 08 01394f14 1024
Scheme 13. Synthesis of dihydrobenzothiophene.
Scheme 13. Synthesis of dihydrobenzothiophene.
Marinedrugs 08 01394f14
Marinedrugs 08 01394f15 1024
Scheme 14. Synthesis of α-azidodihydrobenzothiophene derivatives.
Scheme 14. Synthesis of α-azidodihydrobenzothiophene derivatives.
Marinedrugs 08 01394f15
Marinedrugs 08 01394f16 1024
Scheme 15. A plausible reaction mechanism for α-azidation of dihydrobenzothiophene derivatives.
Scheme 15. A plausible reaction mechanism for α-azidation of dihydrobenzothiophene derivatives.
Marinedrugs 08 01394f16
Marinedrugs 08 01394f17 1024
Scheme 16. The synthesis of 2-azido-5-bromo-6-hydroxydihydrobenzothiophene (72).
Scheme 16. The synthesis of 2-azido-5-bromo-6-hydroxydihydrobenzothiophene (72).
Marinedrugs 08 01394f17
Marinedrugs 08 01394f18 1024
Scheme 17. The total synthesis of (±)-makaluvamine F (48).
Scheme 17. The total synthesis of (±)-makaluvamine F (48).
Marinedrugs 08 01394f18
Marinedrugs 08 01394f19 1024
Scheme 18. Synthetic approach of discorhabdin A from makaluvamine F.
Scheme 18. Synthetic approach of discorhabdin A from makaluvamine F.
Marinedrugs 08 01394f19
Marinedrugs 08 01394f20 1024
Scheme 19. The synthesis of spirodienone.
Scheme 19. The synthesis of spirodienone.
Marinedrugs 08 01394f20
Marinedrugs 08 01394f21 1024
Scheme 20. The total synthesis of (+)-discorhabdin A.
Scheme 20. The total synthesis of (+)-discorhabdin A.
Marinedrugs 08 01394f21
Marinedrugs 08 01394f22 1024
Scheme 21. The semi-synthesis of discorhabdin P and U.
Scheme 21. The semi-synthesis of discorhabdin P and U.
Marinedrugs 08 01394f22
Marinedrugs 08 01394f23 1024
Scheme 22. Synthetic strategy for prianosin B.
Scheme 22. Synthetic strategy for prianosin B.
Marinedrugs 08 01394f23
Marinedrugs 08 01394f24 1024
Scheme 23. Model study using various oxidants.
Scheme 23. Model study using various oxidants.
Marinedrugs 08 01394f24
Marinedrugs 08 01394f25 1024
Scheme 24. The total synthesis of prianosin B.
Scheme 24. The total synthesis of prianosin B.
Marinedrugs 08 01394f25
Marinedrugs 08 01394f26 1024
Scheme 25. The reaction of N-H spirodienone, TsN3 and NaH.
Scheme 25. The reaction of N-H spirodienone, TsN3 and NaH.
Marinedrugs 08 01394f26
Marinedrugs 08 01394f27 1024
Scheme 26. A plausible mechanism for the dehydrogenation reaction of pyrroloiminoquinone using NaN3.
Scheme 26. A plausible mechanism for the dehydrogenation reaction of pyrroloiminoquinone using NaN3.
Marinedrugs 08 01394f27

Share and Cite

MDPI and ACS Style

Wada, Y.; Fujioka, H.; Kita, Y. Synthesis of the Marine Pyrroloiminoquinone Alkaloids, Discorhabdins. Mar. Drugs 2010, 8, 1394-1416. https://doi.org/10.3390/md8041394

AMA Style

Wada Y, Fujioka H, Kita Y. Synthesis of the Marine Pyrroloiminoquinone Alkaloids, Discorhabdins. Marine Drugs. 2010; 8(4):1394-1416. https://doi.org/10.3390/md8041394

Chicago/Turabian Style

Wada, Yasufumi, Hiromichi Fujioka, and Yasuyuki Kita. 2010. "Synthesis of the Marine Pyrroloiminoquinone Alkaloids, Discorhabdins" Marine Drugs 8, no. 4: 1394-1416. https://doi.org/10.3390/md8041394

APA Style

Wada, Y., Fujioka, H., & Kita, Y. (2010). Synthesis of the Marine Pyrroloiminoquinone Alkaloids, Discorhabdins. Marine Drugs, 8(4), 1394-1416. https://doi.org/10.3390/md8041394

Article Metrics

Back to TopTop